Epilepsy, a complex neurological disorder characterized by recurrent seizures, poses significant challenges to patients and healthcare providers alike.1 Pharmacotherapy remains a cornerstone of epilepsy treatment, and the paper explores the latest advancements in antiepileptic drugs (AEDs), highlighting novel agents and their mechanisms of action.2 Additionally, it discusses the challenges posed by drug-resistant epilepsy and explores alternative treatment options, such as neurostimulation and neuromodulation devices. Innovative techniques, such as deep brain stimulation (DBS) and vagus nerve stimulation (VNS) are reviewed in detail, emphasizing their potential as adjunctive therapies for seizure control. Surgical interventions, including resective surgery, laser interstitial thermal therapy (LITT), and functional hemispherectomy, are discussed as viable options for patients with medication-resistant epilepsy.3 This review aims to provide an encompassing exploration of types and characteristics of treatment products, and an in-depth analysis of the market, including market size, distribution, and current trends. Additionally, it will conclude by presenting an overview of emerging approaches in epilepsy treatment for potential clinical applications.